1,3-Disubstituted thiourea compounds and preparation thereof
    2.
    发明授权
    1,3-Disubstituted thiourea compounds and preparation thereof 失效
    1,3-二取代硫脲化合物及其制备

    公开(公告)号:US3992391A

    公开(公告)日:1976-11-16

    申请号:US280953

    申请日:1972-08-16

    IPC分类号: C07D213/75 C07D213/74

    CPC分类号: C07D213/75

    摘要: 1,3-Disubstituted thiourea compounds represented by the following formula: ##EQU1## and their pharmaceutically acceptable acid addition salts which are useful especially for prevention and treatment of hypoxemia and further various diseases caused by hypoxia in local tissues, and process for the preparation of the present compounds set forth above and pharmaceutical composition containing the present compounds as an essential active ingredient.

    摘要翻译: 由下式表示的1,3-二取代硫脲化合物:R-HNCNH-R'PARALLEL S及其药学上可接受的酸加成盐,其特别用于预防和治疗低氧血症以及局部组织中由缺氧引起的各种疾病,以及 制备本发明化合物的方法和含有本发明化合物作为必需活性成分的药物组合物。

    2-(1-piperazinyl)-4-substituted phenylquinoline derivatives, processes
for the preparation thereof, and pharmaceutical composition containing
the same
    4.
    发明授权
    2-(1-piperazinyl)-4-substituted phenylquinoline derivatives, processes for the preparation thereof, and pharmaceutical composition containing the same 失效
    2-(1-哌嗪基)-4-取代苯基喹啉衍生物,其制备方法和含有它们的药物组合物

    公开(公告)号:US4758566A

    公开(公告)日:1988-07-19

    申请号:US893311

    申请日:1986-07-28

    CPC分类号: C07D215/38

    摘要: Compounds of the formula: ##STR1## wherein R.sub.1 represents fluorine atom at the para position, chlorine atom at the para position, methyl group at the para position or trifluoromethyl group at the para or meta position; and R.sub.2 represents hydrogen atom, methyl group, ethyl group, 2-hydroxyethyl group or 3-hydroxypropyl group, provided that R.sub.2 represents ethyl group, 2-hydroxyethyl group or 3-hydroxypropyl group when R.sub.1 represents fluorine atom at the para position, methyl group at the para position or trifluoromethyl group at the para position, and a pharmaceutically acceptable salt therof, process for the preparation thereof, and pharmaceutical composition containing the same. The compounds and pharmaceutically acceptable salts thereof show excellent cytoprotective effect and useful for prophylaxis and treatment of peptic ulcer and inflammatory gastrointestinal diseases.

    摘要翻译: PCT No.PCT / JP85 / 00654 Sec。 371日期1986年7月28日第 102(e)日期1986年7月28日PCT提交1985年11月27日PCT公布。 公开号WO86 / 03198 日期:1986年6月5日。下式的化合物:其中R1表示对位的氟原子,对位的氯原子,对位的甲基或对位或间位的三氟甲基; R2表示氢原子,甲基,乙基,2-羟乙基或3-羟丙基,条件是当R1表示对位的氟原子时,R2表示乙基,2-羟基乙基或3-羟丙基,甲基 在对位或在对位的三氟甲基,和其药学上可接受的盐,其制备方法和含有它们的药物组合物。 所述化合物及其药学上可接受的盐显示出优异的细胞保护作用并且可用于预防和治疗消化性溃疡和炎性胃肠道疾病。

    Anti-peptic ulcer agent
    5.
    发明授权
    Anti-peptic ulcer agent 失效
    抗消化性溃疡剂

    公开(公告)号:US4677107A

    公开(公告)日:1987-06-30

    申请号:US784215

    申请日:1985-10-04

    摘要: Use of a compound of the formula: ##STR1## wherein R is hydrogen atom or ethyl group, or a pharmaceutically acceptable salt thereof for prophylaxis and/or treatment of peptic ulcer, and a method for prophylaxis and/or treatment of peptic ulcer disease which comprises administering an effective amount of the above-mentioned compound to warm blooded aninal, especially human. Said active compounds have excellent pharmacological activities such as inhibition of ulceration and inhibition of gastric secretion, and hence, are useful as an anti-peptic ulcer agent.

    摘要翻译: 下式化合物:其中R是氢原子或乙基的化合物或其药学上可接受的盐用于消化性溃疡的预防和/或治疗,以及预防和/或治疗消化性溃疡疾病的方法,其中 包括将有效量的上述化合物给予温血的阴性,特别是人。 所述活性化合物具有优异的药理活性,例如抑制溃疡和抑制胃分泌,因此可用作抗消化性溃疡剂。